IL-5 Inhibition as a Therapy for Allergic Disease

ISSN： 1094-5539

Source： Pulmonary Pharmacology & Therapeutics, Vol.12, Iss.2, 1999-04, pp. : 81-85

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The inhibition of interleukin 5 in allergic diseases

By Minnicozzi M.

Expert Opinion on Therapeutic Patents, Vol. 9, Iss. 2, 1999-02 ,pp. : 147-156

Informa Healthcare

Access to resources Recommend Favorite

Nanoparticle Therapy for Allergic and Inflammatory Disease

Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Inflammatory and Anti-Allergy Agents), Vol. 9, Iss. 1, 2010-03 ,pp. : 54-70

Bentham Science Publishers

Access to resources Recommend Favorite

Inhibition of BACE, a Promising Approach to Alzheimer's Disease Therapy

Current Topics in Medicinal Chemistry, Vol. 2, Iss. 4, 2002-04 ,pp. : 359-370

Bentham Science Publishers

Access to resources Recommend Favorite

Novel therapy for Crohn’s disease targeting IL-6 signalling

By Ito Hiroaki

Expert Opinion on Therapeutic Targets, Vol. 8, Iss. 4, 2004-08 ,pp. : 287-294

Informa Healthcare

Access to resources Recommend Favorite

Gene Therapy for Allergic Diseases

Current Gene Therapy, Vol. 9, Iss. 3, 2009-06 ,pp. : 185-191

Bentham Science Publishers

Access to resources Recommend Favorite